The global health and economic burden of hospitalizations for heart failure: Lessons learned from hospitalized heart failure registries

Journal of the American College of Cardiology

Volumn 63, Issue 12, 2014, Pages 1123-1133

  Ambrosy, Andrew P ^a   Fonarow, Gregg C ^b   Butler, Javed ^c   Chioncel, Ovidiu ^d   Greene, Stephen J ^e   Vaduganathan, Muthiah ^f   Nodari, Savina ^g   Lam, Carolyn S P ^h   Sato, Naoki ⁱ   Shah, Ami N ^e   Gheorghiade, Mihai ^e  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Prof Dr CC Iliescu Institute of Emergency for Cardiovascular Diseases   (Romania)

^e NORTHWESTERN UNIVERSITY   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g UNIVERSITY OF BRESCIA   (Italy)

^h National University Centre for Oral Health   (Singapore)

ⁱ NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

Author keywords

acute; heart failure; hospitalization; inpatient; registry

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CLINICAL FEATURE; COMORBIDITY; DEMOGRAPHY; DEVICE THERAPY; DISEASE CLASSIFICATION; DISEASE REGISTRY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; EUROPE; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEART EJECTION FRACTION; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; UNITED STATES; COST OF ILLNESS; HOSPITAL PATIENT; HOSPITALIZATION COST; LENGTH OF STAY; MORBIDITY; MORTALITY; PATIENT CARE; PATIENT INFORMATION;

ACUTE; HEART FAILURE; HOSPITALIZATION; INPATIENT; REGISTRY;

ADRENERGIC BETA-ANTAGONISTS; AGE DISTRIBUTION; AGED; ANEMIA; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASIA; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOTONIC AGENTS; CATHETERIZATION, SWAN-GANZ; COMORBIDITY; CORONARY ANGIOGRAPHY; DEFIBRILLATORS, IMPLANTABLE; DIURETICS; DRUG UTILIZATION; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EUROPE; EVIDENCE-BASED MEDICINE; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; HYPONATREMIA; LENGTH OF STAY; MALE; MINERALOCORTICOID RECEPTOR ANTAGONISTS; NATRIURETIC PEPTIDES; QUALITY IMPROVEMENT; REGISTRIES; SEX DISTRIBUTION; STROKE VOLUME; UNITED STATES; VASODILATOR AGENTS;

EID: 84896961871     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.11.053     Document Type: Review

References (87)

1. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones et al. Executive summary: heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 2012 188 197
2. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones et al. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 2012 e2 e220
3. P.A. Heidenreich, N.M. Albert, and L.A. Allen et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association Circ Heart Fail 6 2013 606 619
4. K. Dickstein, A. Cohen-Solal, and G. Filippatos et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology Eur J Heart Fail 10 2008 933 989
5. K. Dickstein, A. Cohen-Solal, and G. Filippatos et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology Eur Heart J 29 2008 2388 2442
6. S. Blecker, M. Paul, G. Taksler, G. Ogedegbe, and S. Katz Heart failure associated hospitalizations in the United States J Am Coll Cardiol 61 2013 1259 1267
7. F. Alla, F. Zannad, and G. Filippatos Epidemiology of acute heart failure syndromes Heart Fail Rev 12 2007 91 95
8. F. Zannad, N. Agrinier, and F. Alla Heart failure burden and therapy Europace 11 Suppl 5 2009 1 9
9. J. Chen, S.L. Normand, Y. Wang, and H.M. Krumholz National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008 JAMA 306 2011 1669 1678
10. M. Gheorghiade, and E. Braunwald Hospitalizations for heart failure in the United States - a sign of hope JAMA 306 2011 1705 1706
11. M. Schaufelberger, K. Swedberg, M. Koster, M. Rosen, and A. Rosengren Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; data from the Swedish Hospital Discharge Registry 1988 to 2000 Eur Heart J 25 2004 300 307
12. S. Stewart, K. MacIntyre, M.M. MacLeod, A.E. Bailey, S. Capewell, and J.J. McMurray Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak? Eur Heart J 22 2001 209 217
13. A. Mosterd, J.B. Reitsma, and D.E. Grobbee Angiotensin converting enzyme inhibition and hospitalisation rates for heart failure in the Netherlands, 1980 to 1999: the end of an epidemic? Heart 87 2002 75 76
14. J.E. Blair, F. Zannad, and M.A. Konstam et al. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program J Am Coll Cardiol 52 2008 1640 1648
15. K.F. Adams Jr., G.C. Fonarow, and C.L. Emerman et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J 149 2005 209 216
16. M. Gheorghiade, W.T. Abraham, and N.M. Albert et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure JAMA 296 2006 2217 2226
17. B.A. Steinberg, X. Zhao, and P.A. Heidenreich et al. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes Circulation 126 2012 65 75
18. M.S. Nieminen, D. Brutsaert, and K. Dickstein et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population Eur Heart J 27 2006 2725 2736
19. A.P. Maggioni, U. Dahlstrom, and G. Filippatos et al. EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot) Eur J Heart Fail 12 2010 1076 1084
20. F. Oliva, A. Mortara, and G. Cacciatore et al. Acute heart failure patient profiles, management and in-hospital outcome: results of the Italian Registry on Heart Failure Outcome Eur J Heart Fail 14 2012 1208 1217
21. F. Zannad, A. Mebazaa, and Y. Juilliere et al. Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study Eur J Heart Fail 8 2006 697 705
22. O. Chioncel, D. Vinereanu, and M. Datcu et al. The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry Am Heart J 162 2011 142 153.e1
23. J. Spinar, J. Parenica, and J. Vitovec et al. Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry Crit Care 15 2011 R291
24. N. Sato, K. Kajimoto, and T. Keida et al. Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry) Circ J 77 2013 944 951
25. J.J. Atherton, C.S. Hayward, and W.A. Wan Ahmad et al. Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific) J Card Fail 18 2012 82 88
26. F. Follath, M.B. Yilmaz, and J.F. Delgado et al. Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF) Intensive Care Med 37 2011 619 626
27. J. Butler, G.C. Fonarow, and M. Gheorghiade Strategies and opportunities for drug development in heart failure JAMA 309 2013 1593 1594
28. M. Vaduganathan, R.O. Bonow, and M. Gheorghiade Thirty-day readmissions: the clock is ticking JAMA 309 2013 345 346
29. E.M. Hsich, and I.L. Pina Heart failure in women: a need for prospective data J Am Coll Cardiol 54 2009 491 498
30. S. Yusuf, M.A. Pfeffer, and K. Swedberg et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Lancet 362 2003 777 781
31. M. Galvao, J. Kalman, and T. DeMarco et al. Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE) J Card Fail 12 2006 100 107
32. E.M. Hsich, M.V. Grau-Sepulveda, and A.F. Hernandez et al. Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction Am Heart J 163 2012 430 437 437 e1-3
33. K.L. Thomas, A.F. Hernandez, and D. Dai et al. Association of race/ethnicity with clinical risk factors, quality of care, and acute outcomes in patients hospitalized with heart failure Am Heart J 161 2011 746 754
34. S.A. Kamath, M.H. Drazner, J. Wynne, G.C. Fonarow, and C.W. Yancy Characteristics and outcomes in African American patients with decompensated heart failure Archives of internal medicine 168 2008 1152 1158
35. C.W. Yancy, W.T. Abraham, and N.M. Albert et al. Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry J Am Coll Cardiol 51 2008 1675 1684
36. C.W. Yancy, M. Lopatin, L.W. Stevenson, T. De Marco, and G.C. Fonarow Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database J Am Coll Cardiol 47 2006 76 84
37. S.J. Shah, and M. Gheorghiade Heart failure with preserved ejection fraction: treat now by treating comorbidities JAMA 300 2008 431 433
38. G.C. Fonarow, W.G. Stough, and W.T. Abraham et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry J Am Coll Cardiol 50 2007 768 777
39. G.C. Fonarow, and E. Corday Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry Heart Fail Rev 9 2004 179 185
40. J.B. Young, W.T. Abraham, and N.M. Albert et al. Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry) Am J Cardiol 101 2008 223 230
41. M. Gheorghiade, W.T. Abraham, and N.M. Albert et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry Eur Heart J 28 2007 980 988
42. J.T. Heywood, G.C. Fonarow, M.R. Costanzo, V.S. Mathur, J.R. Wigneswaran, and J. Wynne High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database J Card Fail 13 2007 422 430
43. N.C. Wang, A.P. Maggioni, and M.A. Konstam et al. Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction JAMA 299 2008 2656 2666
44. R.M. Lang, M. Bierig, and R.B. Devereux et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
45. M. Gheorghiade, and A. Ambrosy Heart failure in 2010: one step forward, two steps back Nat Rev Cardiol 8 2011 72 73
46. M. Vaduganathan, S.J. Greene, A.P. Ambrosy, M. Gheorghiade, and J. Butler The disconnect between phase II and phase III trials of drugs for heart failure Nat Rev Cardiol 10 2013 85 97
47. W.T. Abraham, K.F. Adams, and G.C. Fonarow et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE) J Am Coll Cardiol 46 2005 57 64
48. W.A. Gattis, C.M. O'Connor, V. Hasselblad, K.F. Adams Jr., I. Kobrin, and M. Gheorghiade Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial) Am J Cardiol 93 2004 1436 1437 A10
49. J.L. Januzzi Jr., G. Filippatos, M. Nieminen, and M. Gheorghiade Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section Eur Heart J 33 2012 2265 2271
50. R.D. Kociol, P.S. Pang, M. Gheorghiade, G.C. Fonarow, C.M. O'Connor, and G.M. Felker Troponin elevation in heart failure prevalence, mechanisms, and clinical implications J Am Coll Cardiol 56 2010 1071 1078
51. C. Binanay, R.M. Califf, and V. Hasselblad et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial JAMA 294 2005 1625 1633
52. W.A. Gattis, C.M. O'Connor, D.S. Gallup, V. Hasselblad, and M. Gheorghiade Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial J Am Coll Cardiol 43 2004 1534 1541
53. M. Gheorghiade, W.A. Gattis, M.A. Lukas, and C.M. O'Connor Rationale and design of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) study Am Heart J 145 2003 S60 S61
54. J. Butler, P.G. Arbogast, J. Daugherty, M.K. Jain, W.A. Ray, and M.R. Griffin Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge J Am Coll Cardiol 43 2004 2036 2043
55. A. Ambrosy, and M. Gheorghiade Eplerenone reduces risk of cardiovascular death or hospitalisation in heart failure patients with reduced ejection fraction Evidence-based medicine 16 2011 121 122
56. D.N. Juurlink, M.M. Mamdani, and D.S. Lee et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study N Engl J Med 351 2004 543 551
57. A.P. Maggioni, S.D. Anker, and U. Dahlstrom et al. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry Eur J Heart Fail 15 2013 1173 1184
58. N.C. Wang, G.C. Fonarow, and M. Gheorghiade The potential application of electrophysiology diagnostics and therapeutics in acute heart failure syndromes Heart Fail Rev 16 2011 437 439
59. N.C. Wang, S. Bhattacharya, and M. Gheorghiade The potential role of cardiac resynchronization therapy in acute heart failure syndromes Heart Fail Rev 16 2011 481 490
60. N.C. Wang, J.P. Piccini, and M. Gheorghiade Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions Heart Fail Rev 16 2011 477 480
61. A.P. Maggioni, U. Dahlstrom, and G. Filippatos et al. EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot) Eur J Heart Fail 15 2013 808 817
62. C.M. O'Connor, A.B. Miller, and J.E. Blair et al. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program Am Heart J 159 2010 841 849.e1
63. G.C. Fonarow, W.T. Abraham, and N.M. Albert et al. Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF) Am J Cardiol 104 2009 107 115
64. J.S. Rossi, J.D. Flaherty, and G.C. Fonarow et al. Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: a report from OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Eur J Heart Fail 10 2008 1215 1223
65. S.E. Mountantonakis, M.V. Grau-Sepulveda, D.L. Bhatt, A.F. Hernandez, E.D. Peterson, and G.C. Fonarow Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of get with the guidelines-heart failure Circ Heart Fail 5 2012 191 201
66. G.C. Fonarow, W.T. Abraham, and N.M. Albert et al. Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Am J Cardiol 102 2008 1524 1529
67. B.H. Greenberg, W.T. Abraham, and N.M. Albert et al. Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) Am Heart J 154 2007 277.e1 277.e8
68. R.J. Mentz, M. Fiuzat, and D.M. Wojdyla et al. Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF Eur J Heart Fail 14 2012 395 403
69. W.T. Abraham, G.C. Fonarow, and N.M. Albert et al. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) J Am Coll Cardiol 52 2008 347 356
70. G.C. Fonarow, W.F. Peacock, C.O. Phillips, M.M. Givertz, and M. Lopatin Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure J Am Coll Cardiol 49 2007 1943 1950
71. G.C. Fonarow, W.F. Peacock, and T.B. Horwich et al. Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE Am J Cardiol 101 2008 231 237
72. W.F.t Peacock, T. De Marco, and G.C. Fonarow et al. Cardiac troponin and outcome in acute heart failure N Engl J Med 358 2008 2117 2126
73. G.C. Fonarow, W.T. Abraham, and N.M. Albert et al. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) Am Heart J 153 2007 82.e1 82.e11
74. G.C. Fonarow, W.T. Abraham, and N.M. Albert et al. Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program J Am Coll Cardiol 52 2008 190 199
75. G.C. Fonarow, K.F. Adams Jr., W.T. Abraham, C.W. Yancy, and W.J. Boscardin Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis JAMA 293 2005 572 580
76. C.M. O'Connor, W.T. Abraham, and N.M. Albert et al. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) Am Heart J 156 2008 662 673
77. G. Giamouzis, A. Kalogeropoulos, and V. Georgiopoulou et al. Hospitalization epidemic in patients with heart failure: risk factors, risk prediction, knowledge gaps, and future directions J Card Fail 17 2011 54 75
78. G.C. Fonarow, J.T. Heywood, P.A. Heidenreich, M. Lopatin, and C.W. Yancy Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J 153 2007 1021 1028
79. G.C. Fonarow, W.T. Abraham, and N.M. Albert et al. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design Am Heart J 148 2004 43 51
80. G.C. Fonarow, W.T. Abraham, and N.M. Albert et al. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) Arch Intern Med 167 2007 1493 1502
81. P.A. Heidenreich, W.R. Lewis, K.A. LaBresh, L.H. Schwamm, and G.C. Fonarow Hospital performance recognition with the Get With The Guidelines Program and mortality for acute myocardial infarction and heart failure Am Heart J 158 2009 546 553
82. M. Gheorghiade, and R.O. Bonow Heart failure: Early follow-up after hospitalization for heart failure Nat Rev Cardiol 7 2010 422 424
83. M. Metra, M. Gheorghiade, R.O. Bonow, and L. Dei Cas Postdischarge assessment after a heart failure hospitalization: the next step forward Circulation 122 2010 1782 1785
84. R. Wexler Early physician follow-up and 30-day readmission among older patients with heart failure JAMA 304 2010 743 author reply 743-4
85. A.F. Hernandez, M.A. Greiner, and G.C. Fonarow et al. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure JAMA 303 2010 1716 1722
86. J. Butler, H. Subacius, and M. Vaduganathan et al. Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial J Am Coll Cardiol 61 2013 571 579
87. M. Gheorghiade, M. Vaduganathan, and S.J. Greene et al. Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions Heart Fail Rev 19 2014 135 152